Open AccessImpact of Medication Adherence on Healthcare Resource Utilization, Work Loss, and Associated Costs in a Privately Insured Employed Population Treated With Adalimumab in the United States
Author(s) -
Manish Mittal,
Min Yang,
Manan Shah,
Wei Gao,
Christopher Carley,
Bruce W. Sherman
Publication year - 2021
Publication title -
journal of occupational and environmental medicine
Language(s) - English
Resource type - Journals
eISSN - 1536-5948
pISSN - 1076-2752
DOI - 10.1097/jom.0000000000002354
Subject(s) - adalimumab , medicine , absenteeism , indirect costs , medical costs , health care , retrospective cohort study , cohort , resource use , cohort study , emergency medicine , environmental health , business , disease , management , accounting , economics , economic growth , natural resource economics
The aim of this study was to evaluate the impact of adherence to adalimumab on all-cause work loss, healthcare resource utilization (HRU), and direct medical and indirect costs over 2 years using real-world data.